| 000 | 01820 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514040449.0 | ||
| 264 | 0 | _c20030220 | |
| 008 | 200302s 0 0 eng d | ||
| 022 | _a0168-8278 | ||
| 024 | 7 |
_a10.1016/s0168-8278(02)00107-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFouassier, Laura | |
| 245 | 0 | 0 |
_aContribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan. _h[electronic resource] |
| 260 |
_bJournal of hepatology _cAug 2002 |
||
| 300 |
_a184-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBile Acids and Salts _xmetabolism |
| 650 | 0 | 4 |
_aBile Canaliculi _xdrug effects |
| 650 | 0 | 4 |
_aBilirubin _xmetabolism |
| 650 | 0 | 4 | _aBosentan |
| 650 | 0 | 4 |
_aCholesterol _xmetabolism |
| 650 | 0 | 4 | _aEndothelin Receptor Antagonists |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMembrane Transport Proteins |
| 650 | 0 | 4 | _aMultidrug Resistance-Associated Protein 2 |
| 650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xmetabolism |
| 650 | 0 | 4 |
_aPhospholipids _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Mutant Strains |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aReceptor, Endothelin A |
| 650 | 0 | 4 | _aReceptor, Endothelin B |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aKinnman, Nils | |
| 700 | 1 | _aLefèvre, Guillaume | |
| 700 | 1 | _aLasnier, Elisabeth | |
| 700 | 1 | _aRey, Colette | |
| 700 | 1 | _aPoupon, Raoul | |
| 700 | 1 | _aElferink, Ronald P J Oude | |
| 700 | 1 | _aHousset, Chantal | |
| 773 | 0 |
_tJournal of hepatology _gvol. 37 _gno. 2 _gp. 184-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-8278(02)00107-1 _zAvailable from publisher's website |
| 999 |
_c12017802 _d12017802 |
||